Delivery Order SPE2DB20D1100-SPE2DB25FY61D

Award Date 10/18/24
Potential Completion Date 10/21/24
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of a pharmaceutical product - CIPRO 5% SUSPENSION 100ML. The contract, which has a firm fixed price of $6,296.09, is a delivery order awarded under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,463.78 firm fixed-price contract is for the supply of CIPRO 5% SUSPENSION 100ML, a pharmaceutical product, with a period of performance through June 14, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,655.25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), is for the supply of CIPRO 5% SUSPENSION 100ML, a pharmaceutical product. The IDC, valued at $999,999,999, serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $1,655.55, is a delivery order for the supply of CIPRO 10% SUSPENSION 100ML, a pharmaceutical product. The contract has an ultimate completion date of December 22, 2023 and is a firm fixed-price arrangement. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant Indefinite Delivery...
This is a $3,744.58 Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of CIPRO 5% SUSPENSION 100ML, a pharmaceutical product, with a period of performance through May 13, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,421.44 firm fixed-price delivery order is for the supply of CIPRO 5% SUSPENSION 100ML, a pharmaceutical product, to support federal government healthcare programs. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,515.98, is for the supply of CIPRO 10% SUSPENSION 100ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of August 27, 2024. Amerisourcebergen, through its Corporate Office Division, is the prime contractor for this award, which is...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,313.33, is for the supply of CIPRO 5% SUSPENSION 100ML, a pharmaceutical product. The contract has an ultimate completion date of February 12, 2025 and is a firm fixed-price delivery order. The award does not indicate any set-aside requirements, suggesting open competition. Amerisourcebergen Drug Corp is the prime...
This federal contract award is for the delivery of CIPRO 5% SUSPENSION 100ML medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical, a subordinate organization of the Department of Defense (DoD). The $4,597.18 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of CIPRO 5% SUSPENSION 100ML, a pharmaceutical product, with a ceiling value of $1,407.62 and a completion date of September 19, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FY61D
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,026.59 firm-fixed-price delivery order is for the supply of CIPRO 5% SUSPENSION 100ML, with a period of performance through October 2024.

The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC encompasses a wide variety of critical medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

The contract award did not have a set-aside designation, indicating open competition. No subcontractor information was provided in the details.

Generated 1/17/25, 9:17 AM